IP Library Granted Patent US 12670590
Granted Patent B2
US 12670590 · App. 18/328,442 · Granted Jun 30, 2026

Automated detection of choroidal neovascularization (CNV)

Inventor: Xiaoyong Wang (Burlingame, CA)
Assignee: Genentech, Inc.
G06T7/0012A61B3/0025A61B3/102A61B3/1225G06T7/11G16H50/20G06T2207/10101G06T2207/20084G06T2207/20132G06T2207/30041
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12670590
App. No.
18/328,442
Granted
Jun 30, 2026
Kind
B2
Abstract

A method and system for detecting an advanced stage of age-related macular degeneration in a retina. Optical coherence tomography (OCT) imaging data for a retina is received. A presence of choroidal neovascularization (CNV) in the retina is detected, via a machine learning system, using the OCT imaging data. An output that indicates that the presence of CNV in the retina has been detected is generated.

Claims (49)

1 . A method comprising:

receiving optical coherence tomography (OCT) imaging data for a patient eye;

collapsing the OCT imaging data about a region of interest, to form an OCT input, comprising:

flattening one or more OCT images of the OCT imaging data about a retinal pigment epithelium (RPE) layer of the patient eye;

cropping a number of pixels about the RPE layer;

wherein cropping the number of pixels about the RPE layer comprises cropping a first number of pixels above the RPE layer and a second number of pixels below the RPE layer; and

selecting a predetermined number of central B-scans as the OCT input;

analyzing the OCT input for a presence of choroidal neovascularization (CNV) disease; and

generating an output that indicates the detection of the presence of CNV disease in the patient eye using the OCT input;

wherein the output comprises a margin of error or an uncertainty number.

2 . The method of claim 1 , wherein detecting the presence of CNV disease comprises detecting retinal fluid in the patient eye using the OCT input, wherein the retinal fluid comprises at least one of intraretinal fluid, subretinal fluid, or subretinal pigment epithelial fluid.

3 . The method of claim 2 , wherein the output further comprises a value indicating the amount of retinal fluid in the patient eye.

4 . The method of claim 1 , wherein the detecting the presence of CNV disease is performed using a machine learning system including a recalibration module.

5 . The method of claim 1 , wherein the detecting the presence of CNV disease is performed via a squeeze and excitation module embedded on a machine learning system.

6 . The method of claim 1 , wherein the predetermined number of central B-scans is less than 30.

7 . The method of claim 1 , wherein the output comprises a probability value indicating the probability of the presence of CNV disease.

8 . The method of claim 1 , wherein the first number of pixels is more than twice the second number of pixels.

9 . The method of claim 1 , wherein the first number of pixels is three times more than the second number of pixels.

10 . A system, comprising:

a non-transitory memory; and

a hardware processor coupled with the non-transitory memory and configured to read instructions from the non-transitory memory to cause the system to perform operations comprising:

receiving optical coherence tomography (OCT) imaging data for a patient eye;

collapsing the OCT imaging data about a region of interest, to form an OCT input, comprising:

flattening one or more OCT images of the OCT imaging data about a retinal pigment epithelium (RPE) layer of the patient eye;

cropping a number of pixels about the RPE layer;

wherein cropping the number of pixels about the RPE layer comprises cropping a first number of pixels above the RPE layer and a second number of pixels below the RPE layer; and

selecting a predetermined number of central B-scans as the OCT input;

analyzing the OCT input for a presence of CNV disease; and

generating an output that indicates the detection of the presence of CNV disease in the patient eye using the OCT input;

wherein the output comprises a probability value indicating the probability of the presence of CNV disease and a margin of error or an uncertainty number.

11 . The system of claim 10 , wherein detecting the presence of CNV disease comprises detecting retinal fluid in the patient eye using the OCT input, wherein the retinal fluid comprises at least one of intraretinal fluid, subretinal fluid, or subretinal pigment epithelial fluid.

12 . The system of claim 10 , wherein the detecting the presence of CNV disease is performed using a machine learning system including a recalibration module.

13 . The system of claim 10 , wherein the detecting the presence of CNV disease is performed via a squeeze and excitation module embedded on a machine learning system.

14 . The system of claim 10 , wherein the first number of pixels is more than twice the second number of pixels.

15 . The system of claim 10 , wherein the first number of pixels is three times more than the second number of pixels.

16 . A non-transitory computer-readable medium having stored thereon computer-readable instructions executable to cause a computer system to perform operations comprising:

receiving optical coherence tomography (OCT) imaging data for a patient eye;

collapsing the OCT imaging data about a region of interest, to form an OCT input comprising:

flattening one or more OCT images of the OCT imaging data about a retinal pigment epithelium (RPE) layer of the patient eye;

cropping a number of pixels about the RPE layer;

wherein cropping the number of pixels about the RPE layer comprises cropping a first number of pixels above the RPE layer and a second number of pixels below the RPE layer; and

selecting a predetermined number of central B-scans as the OCT input;

analyzing the OCT input for a presence of CNV disease; and

generating an output that indicates the detection of the presence of CNV disease in the patient eye using the OCT input;

wherein the output comprises a probability value indicating the probability of the presence of CNV disease and a margin of error or an uncertainty number.

17 . The non-transitory computer-readable medium of claim 16 , wherein detecting the presence of CNV disease comprises detecting retinal fluid in the patient eye using the OCT input, wherein the retinal fluid comprises at least one of intraretinal fluid, subretinal fluid, or subretinal pigment epithelial fluid.

18 . The non-transitory computer-readable medium of claim 16 , wherein the detecting the presence of CNV disease is performed via a squeeze and excitation module embedded on a machine learning system.

19 . The non-transitory computer-readable medium of claim 16 , wherein the first number of pixels is more than twice the second number of pixels.

20 . The non-transitory computer-readable medium of claim 16 , wherein the first number of pixels is three times more than the second number of pixels.